Vertex Pharmaceuticals appoints Daniel Brennan to its board of directors
Brennan joins as an independent director, with more than 35 years of finance experience at healthcare companies.
GetSignal Vertex Pharmaceuticals Incorporated VRTX
On October 20, 2026, Vertex Pharmaceuticals announced that Daniel Brennan has been appointed to its Board of Directors as an independent director.
Brennan has more than 35 years of experience in finance roles at healthcare companies, including more than 25 years at Boston Scientific Corporation, a medical device and healthcare technology company.
Key facts
- Appointment
- Daniel Brennan to Board of Directors
- Director type
- Independent director
- Experience
- More than 35 years in finance roles at healthcare companies
- Announced
- October 20, 2026
Source: The company's release on Business Wire, October 20, 2026.
Written by GetSignal with AI from the company's press release.
Not investment advice.
